Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo.
about
Id2 expression delineates differential checkpoints in the genetic program of CD8α+ and CD103+ dendritic cell lineagesT helper 17 cells promote cytotoxic T cell activation in tumor immunityImmunoregulatory functions of immune complexes in vaccine and therapyImmunity to Pathogens Taught by Specialized Human Dendritic Cell SubsetsModes of Antigen Presentation by Lymph Node Stromal Cells and Their Immunological ImplicationsCross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell SubsetsCross-presentation of IgG-containing immune complexesThe Role of FcRn in Antigen PresentationAdaptive immunity to fungiThe chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cellsThe dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed settingDirected antigen targeting in vivo identifies a role for CD103+ dendritic cells in both tolerogenic and immunogenic T-cell responsesDC subset-specific induction of T cell responses upon antigen uptake via Fcγ receptors in vivo.Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenzaPlasmacytoid dendritic cells take up opsonized antigen leading to CD4+ and CD8+ T cell activation in vivo.Bridging innate and adaptive antitumor immunity targeting glycans.Tumor antigen cross-presentation and the dendritic cell: where it all begins?Transcriptional programming of the dendritic cell network.CD8+ T cells are preferentially activated during primary low dose leishmania major infection but are completely dispensable during secondary anti-Leishmania immunityComparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A.Immune-complex mimics as a molecular platform for adjuvant-free vaccine delivery.The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture.Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challengeCyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model.Intracellular regulation of cross-presentation during dendritic cell maturation.Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells.Transmission of murine cytomegalovirus in breast milk: a model of natural infection in neonatesDirect infection of dendritic cells during chronic viral infection suppresses antiviral T cell proliferation and induces IL-10 expression in CD4 T cells.CD8α dendritic cells drive establishment of HSV-1 latencyNondominant CD8 T cells are active players in the vaccine-induced antitumor immune response.Origin, precursors and differentiation of mouse dendritic cells.Dendritic cells as inducers of antimicrobial immunity in vivo.Against the self: dendritic cells versus cancer.Neo-epitopes are required for immunogenicity of the La/SS-B nuclear antigen in the context of late apoptotic cells.How to connect an IgE-driven response with CTL activity?Modulating vaccine responses with dendritic cells and Toll-like receptors.Differential use of autophagy by primary dendritic cells specialized in cross-presentationTranscriptional regulation of dendritic cell diversity.Targeting Dendritic Cells in vivo for Cancer Therapy.IL-12p40/IL-10 Producing preCD8α/Clec9A+ Dendritic Cells Are Induced in Neonates upon Listeria monocytogenes Infection
P2860
Q24617939-B5B2355C-EAE4-44D4-9D83-32D64C2EBFDCQ24646584-2E5D7420-D489-4878-B998-3E1BAE79FC37Q26738396-8CDC6547-6170-4C21-B59F-6E26325BD997Q26777195-D2D5C30A-8DDF-43DA-B894-B91375F49783Q26781338-6AEBB5CC-8F5B-4802-8EF2-28A94B75A502Q26799991-B670F20E-85E3-4BD3-82E3-1638E55167D5Q26825801-E81B2EDD-A2AF-4F6A-B9F1-2AD84B7745D0Q26852988-34B14F7B-495F-4602-8F3A-158A87CFF036Q27025806-B23D6972-F6AD-4F0E-B14D-574E9061F6DDQ28508363-C9E60D21-91CC-4B9B-98EE-EF6C2A5FAC5BQ29618424-D73CDE16-1DBE-43C1-ACF7-2FCFA6C32322Q30505427-B76582C2-A37F-4E43-BD07-65F9615B824DQ33627385-0B28D11F-DA5B-4802-B480-4B4ACC0D9B35Q33658250-50BBD4D2-7507-4DCC-B851-5A85DDFC9DE0Q33907906-F4239B1A-7FD1-44D2-9EF1-BD65E68BA54EQ33960021-955CA478-5456-40E9-A5AF-A7576AAE9065Q34210664-3B568ADB-A166-4906-897C-018C96FECB98Q34249412-308F22E6-E8ED-4C11-BEB0-781E72F0A20EQ34549643-E0282080-A896-4F31-B133-71CB16668E9FQ34573130-69255FE9-69C0-46C6-8E04-D0D081AC7C20Q34700024-6BF20ACA-B887-43AE-8312-4A26485BE588Q34771172-FD80A4CC-DF1A-4A18-A289-2664AB976010Q34855420-C8E51D7B-7664-4D0A-9A07-3CC149B73EF1Q34887495-42BE4601-9C1A-49EA-AA58-0A1B9C37ED7EQ35009666-542B1457-F936-4C72-83C1-373F9FC62ABEQ35049100-988EF385-CB26-47C6-A011-5C9C850EB7F2Q35076650-49AE6740-8682-4FA2-881A-8C36A7B85A79Q35116019-53BD9970-2AF4-4C37-94FE-279DFE27502AQ35138386-BA110E17-8706-410C-9705-A24F48A2CBBEQ35182373-30AA47D4-3EAE-4422-A41E-F079FB6E0CC3Q35183165-60B4821B-2266-4548-8B9C-95E39013262FQ35219298-7CE54E5A-207E-49E8-BDDB-45EFEBEBD0CBQ35219334-61C5C67A-DAE6-4B60-84CF-C3887AD939E7Q35661798-3CD312F9-6DB2-4164-A464-AD5F50427EDDQ35822890-F3E75EE1-EECA-4DA6-BA41-079838B1333BQ35826412-845DFB32-322A-43E9-878C-BBABC3DA5EB3Q35852742-8D8F17F0-1D82-457E-A4B7-FE82CFE0DB1EQ35927398-D4F9836F-47C2-4649-8DC3-14DF6B29D944Q35928270-54F32D46-C813-4F8C-9D01-18307FBCD3A4Q35988496-D516D58D-9EC4-4026-9DE1-1767C154D2FE
P2860
Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Constitutive versus activation ...... D8(-) dendritic cells in vivo.
@ast
Constitutive versus activation ...... D8(-) dendritic cells in vivo.
@en
type
label
Constitutive versus activation ...... D8(-) dendritic cells in vivo.
@ast
Constitutive versus activation ...... D8(-) dendritic cells in vivo.
@en
prefLabel
Constitutive versus activation ...... D8(-) dendritic cells in vivo.
@ast
Constitutive versus activation ...... D8(-) dendritic cells in vivo.
@en
P2860
P356
P1476
Constitutive versus activation ...... D8(-) dendritic cells in vivo.
@en
P2093
Joke M M den Haan
Michael J Bevan
P2860
P304
P356
10.1084/JEM.20020295
P407
P577
2002-09-01T00:00:00Z